An additional fund of RM15 million under the National Covid-19 Immunisation Programme (NIP) has been approved for the third phase of the SARS-CoV-2 genomic surveillance project, said the Science, Technology and Innovation Ministry. 

It said in a statement today that the SARS-CoV-2 genomic surveillance project was very important and strategic to identify and monitor SARS-CoV-2 virus variants in Malaysia, especially variants of concern (VOC) such as Omicron and Delta.